Service Corporation International Valuation
Is SCI * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of SCI * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SCI * (MX$1308.99) is trading above our estimate of fair value (MX$834.18)
Significantly Below Fair Value: SCI * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SCI *?
Other financial metrics that can be useful for relative valuation.
What is SCI *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$10.55b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 3.6x |
Enterprise Value/EBITDA | 12.1x |
PEG Ratio | 4x |
Price to Earnings Ratio vs Peers
How does SCI *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 23x | ||
ALSEA * Alsea. de | 20.8x | 22.3% | Mex$50.0b |
ADT ADT | 42.7x | n/a | US$6.6b |
HRB H&R Block | 11x | -1.1% | US$7.1b |
POSADAS A Grupo Posadas. de | 17.4x | n/a | Mex$13.9b |
SCI * Service Corporation International | 20.1x | 5.1% | Mex$10.5b |
Price-To-Earnings vs Peers: SCI * is good value based on its Price-To-Earnings Ratio (20.1x) compared to the peer average (23x).
Price to Earnings Ratio vs Industry
How does SCI *'s PE Ratio compare vs other companies in the Global Consumer Services Industry?
Price-To-Earnings vs Industry: SCI * is expensive based on its Price-To-Earnings Ratio (20.1x) compared to the Global Consumer Services industry average (16.4x).
Price to Earnings Ratio vs Fair Ratio
What is SCI *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 20.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SCI *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,308.99 | Mex$1,348.62 +3.0% | 4.7% | Mex$1,418.73 | Mex$1,251.82 | n/a | 5 |
Jun ’25 | n/a | Mex$1,348.62 0% | 4.7% | Mex$1,418.73 | Mex$1,251.82 | n/a | 5 |
May ’25 | Mex$1,213.61 | Mex$1,308.43 +7.8% | 6.0% | Mex$1,435.06 | Mex$1,181.81 | n/a | 6 |
Apr ’25 | Mex$1,255.59 | Mex$1,308.43 +4.2% | 6.0% | Mex$1,435.06 | Mex$1,181.81 | n/a | 6 |
Mar ’25 | n/a | Mex$1,301.64 0% | 4.3% | Mex$1,364.16 | Mex$1,193.64 | n/a | 6 |
Feb ’25 | n/a | Mex$1,261.99 0% | 5.2% | Mex$1,376.72 | Mex$1,204.63 | n/a | 6 |
Jan ’25 | n/a | Mex$1,261.99 0% | 5.2% | Mex$1,376.72 | Mex$1,204.63 | n/a | 6 |
Dec ’24 | n/a | Mex$1,235.71 0% | 6.3% | Mex$1,389.09 | Mex$1,128.63 | n/a | 6 |
Nov ’24 | n/a | Mex$1,271.10 0% | 7.6% | Mex$1,427.20 | Mex$1,159.60 | n/a | 4 |
Oct ’24 | n/a | Mex$1,322.99 0% | 3.6% | Mex$1,370.09 | Mex$1,267.33 | n/a | 4 |
Sep ’24 | n/a | Mex$1,344.66 0% | 3.5% | Mex$1,382.69 | Mex$1,278.99 | n/a | 5 |
Aug ’24 | n/a | Mex$1,362.39 0% | 5.0% | Mex$1,433.21 | Mex$1,247.74 | n/a | 5 |
Jul ’24 | n/a | Mex$1,382.65 0% | 5.0% | Mex$1,454.52 | Mex$1,266.29 | n/a | 5 |
Jun ’24 | Mex$1,119.00 | Mex$1,463.13 +30.8% | 5.2% | Mex$1,524.09 | Mex$1,326.86 | n/a | 5 |
May ’24 | n/a | Mex$1,512.15 0% | 5.2% | Mex$1,575.16 | Mex$1,371.32 | Mex$1,213.61 | 5 |
Apr ’24 | Mex$1,229.03 | Mex$1,512.15 +23.0% | 5.2% | Mex$1,575.16 | Mex$1,371.32 | Mex$1,255.59 | 5 |
Mar ’24 | Mex$1,291.44 | Mex$1,512.15 +17.1% | 5.2% | Mex$1,575.16 | Mex$1,371.32 | n/a | 5 |
Feb ’24 | Mex$1,348.00 | Mex$1,540.75 +14.3% | 5.2% | Mex$1,604.94 | Mex$1,397.25 | n/a | 5 |
Jan ’24 | Mex$1,336.00 | Mex$1,579.80 +18.2% | 5.3% | Mex$1,670.19 | Mex$1,454.05 | n/a | 5 |
Dec ’23 | Mex$1,348.00 | Mex$1,579.80 +17.2% | 5.3% | Mex$1,670.19 | Mex$1,454.05 | n/a | 5 |
Nov ’23 | Mex$1,199.03 | Mex$1,570.48 +31.0% | 6.4% | Mex$1,694.04 | Mex$1,434.95 | n/a | 5 |
Oct ’23 | Mex$1,175.23 | Mex$1,623.36 +38.1% | 5.2% | Mex$1,714.11 | Mex$1,492.28 | n/a | 4 |
Sep ’23 | Mex$1,232.00 | Mex$1,623.36 +31.8% | 5.2% | Mex$1,714.11 | Mex$1,492.28 | n/a | 4 |
Aug ’23 | Mex$1,489.03 | Mex$1,620.84 +8.9% | 5.2% | Mex$1,711.44 | Mex$1,489.96 | n/a | 4 |
Jul ’23 | n/a | Mex$1,620.84 0% | 5.2% | Mex$1,711.44 | Mex$1,489.96 | n/a | 4 |
Jun ’23 | Mex$1,306.00 | Mex$1,631.34 +24.9% | 5.2% | Mex$1,722.53 | Mex$1,499.62 | Mex$1,119.00 | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.